Genmab A/S (GMAB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Genmab A/S

    NASDAQ: GMAB · Real-Time Price · USD
    33.56
    1.44 (4.48%)
    At close: Oct 03, 2025, 3:59 PM
    33.58
    0.06%
    After-hours: Oct 03, 2025, 07:41 PM EDT

    Genmab A/S Income Statement

    Financials in DKK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 21.53B 16.47B 14.6B 8.48B
    Cost of Revenue
    		 985M 226M n/a n/a
    Gross Profit
    		 20.54B 16.25B 14.6B 8.48B
    Operating Income
    		 6.7B 5.32B 6.27B 2.95B
    Interest Income
    		 995M 939M 324M 197M
    Pretax Income
    		 9.16B 5.64B 6.95B 3.92B
    Net Income
    		 7.84B 4.35B 5.45B 2.96B
    Selling & General & Admin
    		 3.79B 3.3B 2.68B 1.28B
    Research & Development
    		 9.75B 7.63B 5.56B 4.18B
    Other Expenses
    		 300M n/a n/a n/a
    Operating Expenses
    		 13.84B 10.93B 8.24B 5.46B
    Interest Expense
    		 120M 27M 21M 13M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.82B 11.15B 8.24B 5.46B
    Income Tax Expense
    		 1.32B 1.28B 1.49B 961M
    Shares Outstanding (Basic)
    		 646.34M 659.19M 653.87M 653.96M
    Shares Outstanding (Diluted)
    		 646.33M 659.15M 660.1M 660.46M
    EPS (Basic)
    		 12.14 6.60 8.34 4.52
    EPS (Diluted)
    		 12.14 6.60 8.26 4.48
    EBITDA
    		 9.7B 5.56B 7.35B 3.15B
    EBIT
    		 9.28B 5.71B 6.97B 3.93B
    Depreciation & Amortization
    		 413M 240M 362M 250M

    Add to Watchlist